Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial
2016; Wiley; Volume: 34; Issue: 2 Linguagem: Inglês
10.1111/dme.13279
ISSN1464-5491
AutoresIngrid Schütz-Fuhrmann, Javier Castañeda, Yves Reznik, Ronnie Aronson, Ignacio Conget, S. Liabat, Sarah Runzis, Simona de Portu, Ohad Cohen,
Tópico(s)Diabetes and associated disorders
ResumoDiabetic MedicineVolume 34, Issue 2 p. 291-292 Letters Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial I. Schütz-Fuhrmann, I. Schütz-Fuhrmann Department of Endocrinology, City Hospital Hietzing, Vienna, AustriaSearch for more papers by this authorJ. Castañeda, J. Castañeda Medtronic Bakken Research Center, Maastricht, The NetherlandsSearch for more papers by this authorY. Reznik, Y. Reznik Department of Endocrinology, University of Caen Côte de Nacre Regional Hospital Center, Caen, FranceSearch for more papers by this authorR. Aronson, R. Aronson LMC Diabetes & Endocrinology, Toronto, Ontario, CanadaSearch for more papers by this authorI. Conget, I. Conget Diabetes Unit, Endocrinology and Nutrition Department, University Hospital Clinic, Barcelona, SpainSearch for more papers by this authorS. Liabat, S. Liabat Medtronic International Trading Sàrl, Tolochenaz, SwitzerlandSearch for more papers by this authorS. Runzis, S. Runzis Medtronic International Trading Sàrl, Tolochenaz, SwitzerlandSearch for more papers by this authorS. de Portu, S. de Portu Medtronic International Trading Sàrl, Tolochenaz, SwitzerlandSearch for more papers by this authorO. Cohen, O. Cohen Institute of Endocrinology, Chaim Sheba Medical Center, Tel Hashomer, IsraelSearch for more papers by this author I. Schütz-Fuhrmann, I. Schütz-Fuhrmann Department of Endocrinology, City Hospital Hietzing, Vienna, AustriaSearch for more papers by this authorJ. Castañeda, J. Castañeda Medtronic Bakken Research Center, Maastricht, The NetherlandsSearch for more papers by this authorY. Reznik, Y. Reznik Department of Endocrinology, University of Caen Côte de Nacre Regional Hospital Center, Caen, FranceSearch for more papers by this authorR. Aronson, R. Aronson LMC Diabetes & Endocrinology, Toronto, Ontario, CanadaSearch for more papers by this authorI. Conget, I. Conget Diabetes Unit, Endocrinology and Nutrition Department, University Hospital Clinic, Barcelona, SpainSearch for more papers by this authorS. Liabat, S. Liabat Medtronic International Trading Sàrl, Tolochenaz, SwitzerlandSearch for more papers by this authorS. Runzis, S. Runzis Medtronic International Trading Sàrl, Tolochenaz, SwitzerlandSearch for more papers by this authorS. de Portu, S. de Portu Medtronic International Trading Sàrl, Tolochenaz, SwitzerlandSearch for more papers by this authorO. Cohen, O. Cohen Institute of Endocrinology, Chaim Sheba Medical Center, Tel Hashomer, IsraelSearch for more papers by this author First published: 22 October 2016 https://doi.org/10.1111/dme.13279Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume34, Issue2February 2017Pages 291-292 RelatedInformation
Referência(s)